Cytiva, along with other biopharma manufacturers, continues to face a challenging supply and demand landscape. One of the largest pain points for those involved in process development and manufacturing is the constrained capacity of suppliers which has resulted in difficulties in obtaining materials promptly and in the required quantities. This situation can lead to disruptions in the manufacturing process, causing delays or unexpected downtime. Sourcing is directly linked to occurrences of supply interruptions, delays, and non-availability.
One area that has been particularly impacted by supply chain issues is single-use components, particularly single-use bags used for storing liquid cell culture media and buffers. During the COVID-19 pandemic, Cytiva experienced first-hand how relying on third-party suppliers can negatively affect process development and manufacturing by extending customer wait times for these essential raw materials. Learn how the company secured its single-use bag supply with in-house manufacturing of liquid media bags that offer flexibility in both volume and scale.